Beyond the Hype: Experts Weigh the Promise and Risks of GLP-1 Weight Loss Drugs
For millions of Americans living with obesity and Type 2 diabetes, a new class of medications has brought renewed hope. Drugs such as Ozempic, Wegovy, Mounjaro, and Zepbound have changed
